These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2684472)

  • 1. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I).
    Veng-Pedersen P
    Clin Pharmacokinet; 1989 Nov; 17(5):345-66. PubMed ID: 2684472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
    Rohatagi S; Kan S; Derendorf H
    Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation and estimates of mean residence time with statistical moment theory.
    Kasuya Y; Hirayama H; Kubota N; Pang KS
    Biopharm Drug Dispos; 1987; 8(3):223-34. PubMed ID: 3593900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between in silico physicochemical characteristics of drugs and their mean residence time in human and dog.
    Grabowski T; Jaroszewski JJ; Gad SC; Feder M
    Int J Toxicol; 2012; 31(1):25-33. PubMed ID: 22215410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean time concept and component analysis in pharmacokinetics.
    Brockmeier D
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):555-61. PubMed ID: 10584977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stochastic interpretation of linear pharmacokinetics: a linear system analysis approach.
    Veng-Pedersen P
    J Pharm Sci; 1991 Jul; 80(7):621-31. PubMed ID: 1941557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A versatile computational method for the determination of areas under the curve and moment curve following multidose drug administration.
    Yamashita TS; Lee HL; Reed MD
    Int J Biomed Comput; 1988 Dec; 23(3-4):239-49. PubMed ID: 3225062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean residence time.
    Brockmeier D; von Hattingberg HM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):309-12. PubMed ID: 3724305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of population pharmacokinetic model and parameter analyses for multiple components in Chinese matria medica formula].
    He F; Deng K; Liu W; Shi J; Yang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2866-70. PubMed ID: 22292387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics: statistical moment calculations.
    Gouyette A
    Arzneimittelforschung; 1983; 33(1):173-6. PubMed ID: 6681972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.
    Kong AN; Jusko WJ
    J Pharm Sci; 1988 Feb; 77(2):157-65. PubMed ID: 3361431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
    Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
    Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).
    Veng-Pedersen P
    Clin Pharmacokinet; 1989 Dec; 17(6):424-40. PubMed ID: 2689041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the volume of distribution at steady state and its relationship with two-compartmental models.
    Yates JW; Arundel PA
    J Pharm Sci; 2008 Jan; 97(1):111-22. PubMed ID: 17705153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.